Increased PAC-1 expression among patients with multiple myeloma on concurrent thalidomide and warfarin

Blood Coagulation and Fibrinolysis

Volumn 24, Issue 8, 2013, Pages 893-895

  Abdullah, Wan Z ^a   Roshan, Tariq M ^a   Hussin, Azlan ^a   Zain, Wan S W Md ^a   Abdullah, Dzarr ^a  

^a SCHOOL OF MEDICAL SCIENCES   (Malaysia)

Author keywords

platelet activation markers; thalidomide; thrombosis

Indexed keywords

ANTINEOPLASTIC AGENT; DUAL SPECIFICITY PHOSPHATASE 2; PADGEM PROTEIN; THALIDOMIDE; WARFARIN;

ADULT; ARTICLE; BLOOD SAMPLING; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; FLOW CYTOMETRY; FOLLOW UP; HUMAN; MULTIPLE MYELOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; THROMBOCYTE ACTIVATION; THROMBOCYTE MEMBRANE; THROMBOSIS PREVENTION;

AGED; ANTIBODIES, MONOCLONAL; ANTICOAGULANTS; BLOOD PLATELETS; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; MULTIPLE MYELOMA; P-SELECTIN; PLATELET ACTIVATION; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; THALIDOMIDE; THROMBOSIS; WARFARIN;

EID: 84888130408     PISSN: 09575235     EISSN: 14735733     Source Type: Journal    
DOI: 10.1097/MBC.0b013e3283642ee2     Document Type: Article

References (18)

1. Gachon J, Grob JJ, Richard MA. Thrombotic accidents induced by thalidomide: two cases. Rev Med Interne 2002; 23:724-727.
2. Elice F, Rodeghiero F, Falanga A, Rickles FR. Thrombosis associated with angiogenesis inhibitors. Best Pract Res Clin Haematol 2009; 22:115-128.
3. Dunkley S, Gaudry L. Thalidomide causes platelet activation, which can be abrogated by aspirin. J Thromb Haemost 2007; 5:1323-1325.
4. Ipek Y, Fehmi H, Sevgi BK, Deniz S. Thrombotic complications in multiple myeloma: a report of three cases and review of the literature. J Thromb Thrombolysis 2011; 33:197-201; [Epub ahead of print].
5. Roshan TM, Normah J, Rehman A, Naing L. Effect of menopause on platelet activation markers determined by flow cytometry. Am J Hematol 2005; 80:257-261.
6. Ritchie JL, Alexander HD, Rea IM. Flow cytometry analysis of platelet P-selectin expression in whole blood-methodological considerations. Clin Lab Haematol 2000; 22:359-363.
7. Ritchie JL, Crawford VL, McNulty M, Alexander HD, Stout RW. Effect of tourniquet pressure and intra-individual variability on plasma fibrinogen, platelet P-selectin and monocyte tissue factor. Clin Lab Haematol 2000; 22:369-372.
8. Ikhlaque N, Seshadri V, Kathula S, Baumann MA. Efficacy of prophylactic warfarin for prevention of thalidomide-related deep vein thrombosis. Am J Hematol 2006; 81:420-422.
9. Singh A, Gajra A. Thromboembolism with immunomodulatory agents in the treatment of multiple myeloma. Cardiovasc Hematol Agents Med Chem 2011; 9:7-13.
10. Leung L, Nachman R. Molecular mechanisms of platelet aggregation. Ann Rev Med 1986; 37:179-186.
11. Frenette PS, Johnson RC, Hynes RO, et al. Platelets roll on stimulated endothelium in vivo: an interaction mediated by endothelial P-selectin. Proc Natl Acad Sci U S A 1995; 92:7450-7454.
12. Frojmovic MM, Wong T, van de Ven T. Dynamic measurements of the platelet membrane glycoprotein IIb-IIIa receptor for fibrinogen by flow cytometry, I: methodology, theory and results for two distinct activators. Biophys J 1991; 59:815-827.
13. Mauger N, Malato S, Femia EA, et al. Clearance of circulating activated platelets in polycythemia vera and essential thrombocythemia. Blood 2011; 118:3359-3366.
14. Anderson KC. Lenalidomide and thalidomide: mechanisms of actionsimilarities and differences. Semin Hematol 2005; 42:S3-8.
15. Lebrin F, Srun S, Raymond K, Martin S, van den Brink S, Freitas C, et al. Thalidomide stimulates vessel maturation and reduces epistaxis in individuals with hereditary hemorrhagic telangiectasia. Nat Med 2010; 16:420-428.
16. Falco P, Bertola A, Bringhen S, Cavallo F, Boccadoro M, Palumbo A. Successful management of immune thrombocytopenic purpura with thalidomide in a patient with multiple myeloma. Hematol J 2004; 5:456-457.
17. Cesarman-Maus G, Braggio E, Fonseca R. Thrombosis in multiple myeloma (MM). Hematology 2012; 17:S177-S180.
18. Hoshi A, Matsumoto A, Chung J, Isozumi Y, Koyama T. Activation of coagulation by a thalidomide-based regimen. Blood Coagul Fibrinolysis 2011; 22:532-540